Table of Contents Table of Contents
Previous Page  58 / 60 Next Page
Information
Show Menu
Previous Page 58 / 60 Next Page
Page Background

56

NCCN Guidelines for Patients

®

:

Breast Cancer – Metastatic (STAGE IV), Version 2.2017

Index

Index

2

nd

opinion

44

biopsy

15, 18, 20

bone scan

15, 36–37

cancer stage

12

chemotherapy

22, 24, 28–34, 36–37

clinical trial

22–23, 37

computed tomography (CT)

15–17, 36–37

endocrine therapy

22, 24, 26, 28–30, 34, 36–37

genetic counseling

15, 20

HER2

15, 20, 28–29, 32–37

hormone receptor

15, 22, 24–35, 37

hormone therapy

see endocrine therapy

magnetic resonance imaging (MRI)

15–17

medical history

14–15

NCCN Member Institutions

54

NCCN Panel Members

53

physical exam

14–15, 36–37

positron emission tomography (PET)

15, 17,

36–37

resistance

36

supportive care

22, 24, 36

targeted therapy

22, 24, 26, 30, 32–34, 36–37

triple-negative cancer

34